Accuracy of malaria diagnosis by clinical laboratories in Belgium.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
28 Mar 2019
Historique:
received: 02 08 2018
accepted: 18 03 2019
entrez: 30 3 2019
pubmed: 30 3 2019
medline: 30 4 2019
Statut: epublish

Résumé

The Belgian Reference Laboratory for Plasmodium offers a free-of-charge reference testing of malaria-positive or doubtful samples to clinical laboratories. The final malaria diagnosis from the Reference Laboratory (microscopy, rapid diagnostic tests (RDTs) and Plasmodium species-specific PCR) were compared with the final diagnosis from peripheral Belgian laboratories. The Reference Laboratory reports were analysed for all samples submitted between 2013 and 2017. Criteria assessed included the diagnosis of malaria, Plasmodium species identification including mixed infections, and in case of Plasmodium falciparum, the parasite density and the presence of sexual and asexual stages. A total of 947 non-duplicate samples were included. Reference testing confirmed 96.3% (893/927) and 90.0% (18/20) samples submitted as positive and negative, respectively, the two missed diagnoses were samples with Plasmodium ovale and Plasmodium malariae. Submitting laboratories had correctly identified P. falciparum in 95.1% (508/534) samples with P. falciparum single infection. They had correctly diagnosed the species in 62.9% (95/151) single non-falciparum samples and had reported 'non-falciparum' in another 26 (17.2%) samples; most errors occurred among P. malariae (n = 8/21, 38.1%) and P. ovale (n = 14/51, 27.5%). Only one of the 21 mixed Plasmodium species infections had been diagnosed as such by the submitting laboratories; in three of them, P. falciparum had been overlooked. Taken single and mixed infections together, P. falciparum was diagnosed in 98.6% (546/554) samples. Among 471 single P. falciparum samples available for comparison, laboratories had correctly reported parasite densities above 2% in 87.5% (70/80) samples; they had incorrectly reported parasite densities > 2% in an extra 52 (8.9%) samples. Laboratories had correctly reported P. falciparum schizonts and gametocytes in 25.6% (11/43) and 56.7% (17/30) samples, respectively. Diagnostic laboratories in a malaria non-endemic setting provided excellent diagnosis of malaria and P. falciparum, reasonably good diagnosis of non-falciparum infections and acceptable calculation of P. falciparum parasite density.

Sections du résumé

BACKGROUND BACKGROUND
The Belgian Reference Laboratory for Plasmodium offers a free-of-charge reference testing of malaria-positive or doubtful samples to clinical laboratories.
METHODS METHODS
The final malaria diagnosis from the Reference Laboratory (microscopy, rapid diagnostic tests (RDTs) and Plasmodium species-specific PCR) were compared with the final diagnosis from peripheral Belgian laboratories. The Reference Laboratory reports were analysed for all samples submitted between 2013 and 2017. Criteria assessed included the diagnosis of malaria, Plasmodium species identification including mixed infections, and in case of Plasmodium falciparum, the parasite density and the presence of sexual and asexual stages.
RESULTS RESULTS
A total of 947 non-duplicate samples were included. Reference testing confirmed 96.3% (893/927) and 90.0% (18/20) samples submitted as positive and negative, respectively, the two missed diagnoses were samples with Plasmodium ovale and Plasmodium malariae. Submitting laboratories had correctly identified P. falciparum in 95.1% (508/534) samples with P. falciparum single infection. They had correctly diagnosed the species in 62.9% (95/151) single non-falciparum samples and had reported 'non-falciparum' in another 26 (17.2%) samples; most errors occurred among P. malariae (n = 8/21, 38.1%) and P. ovale (n = 14/51, 27.5%). Only one of the 21 mixed Plasmodium species infections had been diagnosed as such by the submitting laboratories; in three of them, P. falciparum had been overlooked. Taken single and mixed infections together, P. falciparum was diagnosed in 98.6% (546/554) samples. Among 471 single P. falciparum samples available for comparison, laboratories had correctly reported parasite densities above 2% in 87.5% (70/80) samples; they had incorrectly reported parasite densities > 2% in an extra 52 (8.9%) samples. Laboratories had correctly reported P. falciparum schizonts and gametocytes in 25.6% (11/43) and 56.7% (17/30) samples, respectively.
CONCLUSION CONCLUSIONS
Diagnostic laboratories in a malaria non-endemic setting provided excellent diagnosis of malaria and P. falciparum, reasonably good diagnosis of non-falciparum infections and acceptable calculation of P. falciparum parasite density.

Identifiants

pubmed: 30922316
doi: 10.1186/s12936-019-2731-0
pii: 10.1186/s12936-019-2731-0
pmc: PMC6437969
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

Arch Pathol Lab Med. 2000 Jan;124(1):57-60
pubmed: 10629133
Clin Microbiol Infect. 2003 Jun;9(6):497-504
pubmed: 12848724
J Clin Pathol. 2003 Dec;56(12):927-32
pubmed: 14645352
CMAJ. 2005 Jan 4;172(1):46-50
pubmed: 15632404
Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):186-9
pubmed: 16525777
Malar J. 2006 Jul 14;5:57
pubmed: 16842613
Malar J. 2008 Apr 08;7:56
pubmed: 18397524
Malar J. 2010 Dec 13;9:359
pubmed: 21144034
Malar J. 2010 Dec 22;9:370
pubmed: 21176207
Malar J. 2011 Nov 10;10:340
pubmed: 22074250
Malar J. 2012 Sep 17;11:328
pubmed: 22985344
Clin Microbiol Infect. 2013 May;19(5):408-15
pubmed: 23373854
BMJ. 2013 May 21;346:f2900
pubmed: 23693055
Br J Haematol. 2013 Dec;163(5):573-80
pubmed: 24219330
Malar J. 2013 Nov 22;12:428
pubmed: 24261625
Cochrane Database Syst Rev. 2014 Dec 18;(12):CD011431
pubmed: 25519857
J Infect. 2016 Jun;72(6):635-649
pubmed: 26880088
J Clin Pathol. 1994 Aug;47(8):740-2
pubmed: 7962629
J Clin Pathol. 1996 Jul;49(7):533-8
pubmed: 8813948

Auteurs

Laura Loomans (L)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Anali Conesa Botella (A)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. aconesa@itg.be.

Agnes D'hondt (A)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jacob Verschueren (J)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Dorien Van den Bossche (D)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Marjan Van Esbroeck (M)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jan Jacobs (J)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH